Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Pulmonary Hypertension, February 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 159 articles: HTML format

Single Articles

1. CHILINGARASHVILI G, Mylvaganam RJ, Bernardo RJ, Shah A, et al
   Sotatercept in Pulmonary Langerhans Cell Histiocytosis-Associated Pulmonary Hypertension: A Case Series and Systematic Review.
   Pulm Circ. 2026;16:e70239.
   PubMed    
   Abstract available
   
   

2. ALTURAIF N, Alduraibi FK, Marquez K, Alahmadi F, et al
   Pulmonary endarterectomy in antiphospholipid syndrome: a retrospective analysis from the Saudi pulmonary hypertension registry.
   Front Med (Lausanne). 2026;13:1736115.
   PubMed    
   Abstract available
   
   

3. KRONBERGER C, Mousavi RA, Ermolaev N, Poledniczek M, et al
   Performance on the one-minute sit-to-stand test predicts long-term adverse outcomes in pulmonary hypertension.
   Sci Rep. 2026 Jan 29. doi: 10.1038/s41598-026-37611.
   PubMed    
   
   
   

4. BERTHELOT E, Bauer F, Fauvel C, Paclot M, et al
   Echocardiographic Risk Stratification in Heart Failure with Post-Capillary Pulmonary Hypertension: Prognostic Value of LAVI and TAPSE/PASP.
   Eur Heart J Cardiovasc Imaging. 2026 Jan 30:jeag034. doi: 10.1093.
   PubMed    
   Abstract available
   
   

5. PAGNONI G, Vicenzi A, Coppi F
   Designing the right trial for sacubitril / valsartan in heart failure with preserved ejection fraction-related pulmonary hypertension.
   Pol Arch Intern Med. 2026;136:17211.
   PubMed    
   
   
   

6. NIEMIEC M, Grabka M, Niemiec R, Filipecki A, et al
   Designing the right trial for sacubitril / valsartan in heart failure with preserved ejection fraction-related pulmonary hypertension. Authors' reply.
   Pol Arch Intern Med. 2026;136:17212.
   PubMed    
   
   
   

7. AHMED F, Haider F, Ali R, Arham M, et al
   Comparative accuracy of artificial intelligence versus manual interpretation in detecting pulmonary hypertension across chest imaging modalities: a diagnostic test accuracy meta-analysis.
   Front Artif Intell. 2026;8:1709489.
   PubMed    
   Abstract available
   
   

8. KUMAR P, Verma AK, Bajpai J, Kar SK, et al
   Pulmonary hypertension in patients with obstructive sleep apnea: Correlation with disease severity and quality of life.
   World J Cardiol. 2026;18:112541.
   PubMed    
   Abstract available
   
   

9. BAISYA R, Vardhan YK, Gsr M, Vardhan YV, et al
   The Long-Term Outcomes of Pulmonary Hypertension in Systemic Lupus Erythematosus (SLE-PAH) Vary Among Different Autoantibody-Based Clusters: An Observational, Longitudinal Study Conducted at a Single Centre in India.
   Mediterr J Rheumatol. 2025;36:594-599.
   PubMed    
   Abstract available
   
   

10. VENKATESHVARAN A, Lindqvist P, Evaldsson AW
    Right Ventricular Global Wasted Work: Employing Myocardial Energetics for Risk Assessment and Outcome Prediction in Pulmonary Hypertension.
    Eur Heart J Cardiovasc Imaging. 2026 Jan 28:jeag029. doi: 10.1093.
    PubMed    
    
    
    

11. RONG C, Zhang L, Li B, Wang Y, et al
    Efficacy and safety of specific treatment combined with SGLT2-i in pulmonary hypertension.
    Front Cardiovasc Med. 2026;12:1684394.
    PubMed    
    Abstract available
    
    

12. WANG H, Cui M
    Effects of balloon pulmonary angioplasty on cardiac and pulmonary functions and complications in patients with chronic thromboembolic pulmonary hypertension.
    Front Med (Lausanne). 2026;12:1689193.
    PubMed    
    Abstract available
    
    

13. SHEN T, Lv X, Wang C, Ma Q, et al
    Severe pulmonary edema after pulmonary hypertension interventional surgery: case report and literature review.
    Front Med (Lausanne). 2026;12:1723147.
    PubMed    
    Abstract available
    
    

14. SUEBLINVONG V, Chang SS, Ma J, Archer DR, et al
    Long Non-Coding RNA MALAT1 Regulates HMOX1 in Sickle Cell Disease-Associated Pulmonary Hypertension.
    Cells. 2026;15:154.
    PubMed    
    Abstract available
    
    

15. TILEA I, Iancu DG, Fira-Mladinescu O, Bertici N, et al
    Sotatercept in Pulmonary Arterial Hypertension: Molecular Mechanisms, Clinical Evidence, and Emerging Role in Reverse Remodelling.
    Int J Mol Sci. 2026;27:767.
    PubMed    
    Abstract available
    
    

16. BATUM O, Ayik Turk M, Varol Y, Ozyilmaz B, et al
    Genetic and Clinical Determinants of Chronic Thromboembolic Pulmonary Hypertension: The Role of PAI-1 Polymorphism.
    Int J Mol Sci. 2026;27:758.
    PubMed    
    Abstract available
    
    

17. SCAGLIOLA R
    Deciphering the Counterintuitive Role of Vascular Endothelial Growth Factor Signaling Pathways in Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2026;27:687.
    PubMed    
    Abstract available
    
    

18. MILANO G, Ottolenghi S, Zubieta-Calleja G, Beghetti M, et al
    Mechanisms Underlying Altitude-Induced and Group 3 Pulmonary Hypertension.
    Int J Mol Sci. 2026;27:572.
    PubMed    
    Abstract available
    
    

19. YOKOYAMA YM, Watanabe R, Yamaguchi T, Ishihara R, et al
    Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: Current Therapeutic Strategies and Future Prospects.
    Biomolecules. 2026;16:140.
    PubMed    
    Abstract available
    
    

20. OKECHUKWU A, Odetunde O, Uchenna E, Chinawa JM, et al
    Prevalence and severity of persistent pulmonary hypertension of the newborns among asphyxiated neonates admitted in Enugu State University Teaching Hospital.
    BMJ Paediatr Open. 2026;10:e004351.
    PubMed    
    Abstract available
    
    

21. AHMADIPOUR B, Pat S, Khajali F, Hassanpour H, et al
    Effects of Sodium Butyrate Forms on Carcass Performance, Pulmonary Hypertension, Metabolic Health and Oxidative-Inflammatory Responses in Broiler Chickens Under Cold Stress at High Altitude.
    Vet Med Sci. 2026;12:e70720.
    PubMed    
    Abstract available
    
    

22. LIANG S, Wang X, Wu Y
    Establishment of a rat model of bronchopulmonary dysplasia complicated with pulmonary hypertension and its potential applications.
    Hum Exp Toxicol. 2026;45:9603271261420421.
    PubMed    
    Abstract available
    
    

23. GARCIA SM, Lantz BJ, Wagner HJ, Jones DT, et al
    Inducible Ift88-deficient mice show features consistent with mild pulmonary hypertension.
    Physiol Rep. 2026;14:e70749.
    PubMed    
    Abstract available
    
    

24. LECHUGA CG, Kachabi A, Colebank MJ, Korcarz CE, et al
    Patient-Specific Lumped-Parameter Model for Quantifying Vessel-Specific Remodeling and Predicting Right Ventricular Function in Pulmonary Hypertension.
    Compr Physiol. 2026;16:e70102.
    PubMed    
    Abstract available
    
    

25. ZHANG H, Guo X, Han Y
    A tale of two forces: pulmonary hypertension and hepatopulmonary syndrome in congenital portosystemic shunt.
    Eur Heart J. 2026 Jan 13:ehaf820. doi: 10.1093.
    PubMed    
    
    
    

26. HUANG Y, Qin B, Shen B, Zhu J, et al
    Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension: A Comparative Study of Biomarkers and Clinical Indicators.
    Pulm Circ. 2026;16:e70228.
    PubMed    
    Abstract available
    
    

27. SU H, Li B, Guo Z, Zhang F, et al
    Beta-Alanine Supplementation Ameliorates Right Ventricular Remodeling Caused by Monocrotaline-Induced Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70244.
    PubMed    
    Abstract available
    
    

28. MA J, Cao X, Yang X, Zhu Y, et al
    Natural products targeting the immune-metabolic regulatory network in pulmonary hypertension: mechanisms, classification, and therapeutic prospects.
    Front Pharmacol. 2026;16:1712903.
    PubMed    
    Abstract available
    
    

29. LU Z, Zhang C, Wan J, Xiao Y, et al
    Exercise tolerance in patients with chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty.
    Heart Lung. 2026;78:102725.
    PubMed    
    Abstract available
    
    

30. YOKAWA K, Kawakami M, Tanaka Y, Higuma T, et al
    Acute pulmonary hypertension induced by heparin-protamine complex during thoracoabdominal aortic grafting.
    J Cardiothorac Surg. 2026 Jan 24. doi: 10.1186/s13019-025-03807.
    PubMed    
    
    
    

31. REVENKO SV, Tarakanov IA, Tikhomirova LN, Kuropatkina TA, et al
    Effect of Hindlimb Denervation on Survival Rate and Circulation and Respiration Systems in Monocrotaline Rat Model of Pulmonary Arterial Hypertension.
    Bull Exp Biol Med. 2025;179:644-649.
    PubMed    
    Abstract available
    
    

32. CHEN H, Qiu YX, Xie YF, Chen X, et al
    Redox switch C674 in SERCA2 triggers Ca(2+)-calcineurin-MCU-Drp1 cascade and pulmonary vascular remodeling.
    Free Radic Biol Med. 2026;244:380-394.
    PubMed    
    Abstract available
    
    

33. YU L, Hou Z, Han L, An Y, et al
    Clinical and imaging characteristics of pulmonary artery dissection.
    Int J Cardiovasc Imaging. 2026;42:111-117.
    PubMed    
    Abstract available
    
    

34. OU L, Chen Y, Shen A, He S, et al
    Epigenetically activated MIR100HG regulates UPF1-mediated oxidative stress to promote pulmonary vascular immune microenvironment remodeling.
    Free Radic Biol Med. 2026;244:210-228.
    PubMed    
    Abstract available
    
    

35. JIAO Q, Yang Y, Xu X, Hao J, et al
    Therapeutic potential of magnesium diboride nanosheets in PAH-associated right heart failure: Integrated multi-omics analysis reveals ferroptosis suppression via LC3/ATG5/NCOA4/FTH1 pathway.
    Free Radic Biol Med. 2026;244:1-16.
    PubMed    
    Abstract available
    
    

36. QASEM U, Alghwyeen W, Alshqeirat M, Saman R, et al
    Unveiling pleuropulmonary manifestations in systemic lupus erythematosus: a retrospective observational study from the Middle East.
    Clin Rheumatol. 2026;45:151-162.
    PubMed    
    Abstract available
    
    

37. HAYVACI CANBEYLI F, Secgen K, Ezgu FS, Tacoy G, et al
    The Role of Genetics in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension.
    Pediatr Cardiol. 2026;47:821-829.
    PubMed    
    Abstract available
    
    

38. ELSABAN M, Radosevich MA, Pennington KM, Spencer PJ, et al
    Cardiac Arrest in the Setting of Left Lung Herniation Following Combined Heart-Lung Transplant: Case Report.
    ASAIO J. 2025;71:e168-e171.
    PubMed    
    Abstract available
    
    

39. SATPATHY SK, Paswal CM, Gupta N, Soni JP, et al
    Endomyocardial calcification with pulmonary and systemic hypertension in a term neonate with multisystem inflammatory syndrome of newborn (MIS-N).
    BMJ Case Rep. 2026;19:e270053.
    PubMed    
    Abstract available
    
    

40. WU C, Zhao W, Zhu X, Li Y, et al
    Identification and genetic validation of potential therapeutic targets for pulmonary hypertension through multi-omics causal inference.
    Medicine (Baltimore). 2026;105:e47525.
    PubMed    
    Abstract available
    
    

41. 
    A treprostinil inhaler (Yutrepia) for pulmonary hypertension.
    Med Lett Drugs Ther. 2026;68:27-28.
    PubMed    
    
    
    

42. CHEN A, Chen Z, Huang B, Lian G, et al
    Correction to: Hypoxia-induced histone lactylation promotes pulmonary arterial smooth muscle cells proliferation in pulmonary hypertension.
    Mol Cell Biochem. 2026 Feb 5. doi: 10.1007/s11010-026-05493.
    PubMed    
    
    
    

43. SUBEDI BK, Gautam N, Ali R, Tan IJ, et al
    Impact of Hydroxychloroquine on Mortality and Cardiovascular Outcomes in Systemic Sclerosis: A Retrospective Cohort Study.
    Int J Rheum Dis. 2026;29:e70515.
    PubMed    
    Abstract available
    
    

44. LI SS, Guo M, Zhao Y, Huang S, et al
    circMFN2 Regulates the IGF2BP3-PDK4 to Ameliorate Pulmonary Hypertension.
    Hypertension. 2026 Feb 5. doi: 10.1161/HYPERTENSIONAHA.125.25460.
    PubMed    
    Abstract available
    
    

45. SUZUKI Y, Nagaoka T, Nagata Y, Terayama Y, et al
    Transplantation of Ex Vivo Amplified Mononuclear Cells From Peripheral Blood Improves Rat Pulmonary Hypertension via CD14- and CD163-Positive M2 Macrophages.
    Respirology. 2026 Feb 4. doi: 10.1002/resp.70206.
    PubMed    
    Abstract available
    
    

46. PAEZ-CARPIO A, Domenech-Ximenos B, Serrano E, Cornellas L, et al
    Vascular Obstruction Scoring on Dual-energy CT, Cone-beam CT and Digital Subtraction Angiography: Correlation with Invasive Hemodynamics in Chronic Thromboembolic Pulmonary Hypertension.
    Acad Radiol. 2026 Feb 3:S1076-6332(26)00019-X. doi: 10.1016/j.acra.2026.
    PubMed    
    Abstract available
    
    

47. LIU T, Zhou W, Fang C, Liang Y, et al
    Sine oculis homeobox 1 drives endothelial dysfunction in preclinical pulmonary arterial hypertension.
    Sci Transl Med. 2026;18:eadu6425.
    PubMed    
    Abstract available
    
    

48. TAKITA Y, Morishita J, Park S, Goda A, et al
    Mindfulness-Based Self-Management Program Using a Mobile App for Patients With Pulmonary Hypertension: Single-Arm Feasibility Study.
    JMIR Cardio. 2026;10:e79639.
    PubMed    
    Abstract available
    
    

49. ROQUE AC, Stockmann IS, Acencio MMP, Silva CSR, et al
    IL-6 and TGF-beta1 as biomarkers of schistosomiasis-associated pulmonary hypertension in a murine model.
    Braz J Med Biol Res. 2026;59:e15221.
    PubMed    
    Abstract available
    
    

50. FILIPIAK J, Dzikowska-Diduch O, Justyna A, Labyk A, et al
    How long does chronic thromboembolic pulmonary hypertension take to develop? Two cases of post?thrombotic complete occlusion of the left pulmonary artery.
    Pol Arch Intern Med. 2026 Feb 3:17220. doi: 10.20452/pamw.17220.
    PubMed    
    
    
    

51. PLUNKETT MJ, Sayegh ALC, Lewis RA, McWilliams TJ, et al
    Sympatho-Excitation in Pulmonary Hypertension: The Potential Role of Pulmonary Arterial Baroreceptors: An Acute Physiologic Intervention Study.
    Respirology. 2026 Feb 3. doi: 10.1002/resp.70207.
    PubMed    
    Abstract available
    
    

52. FENG W, Bai D, Mo S, Wen D, et al
    Echinatin Alleviates Experimental Pulmonary Hypertension by PPARgamma Pathway Activation.
    FASEB J. 2026;40:e71542.
    PubMed    
    Abstract available
    
    

53. CHI L, Foley AE, Goodarzi G, Volchuk A, et al
    The hypoxic tight-skin mouse model of Group 3 pulmonary hypertension.
    Sci Rep. 2026 Feb 2. doi: 10.1038/s41598-026-38174.
    PubMed    
    Abstract available
    
    

54. JIANG YH, Zhang ZL, Qin N, Luo XY, et al
    [Role of macrophages in pulmonary arterial hypertension and advances in targeted therapeutic interventions].
    Zhonghua Jie He He Hu Xi Za Zhi. 2026;49:215-222.
    PubMed    
    Abstract available
    
    

55. HOMEDI A, Ali Ali K, Almehaid A, Alrahili M, et al
    Targeted Neonatal Echocardiography and Neonatal Hemodynamics in the Kingdom of Saudi Arabia: A One-Year Experience in Service Implementation.
    Saudi Med J. 2026;47:60-66.
    PubMed    
    Abstract available
    
    

56. BOCHENEK ML, Ghasemi I, Wiedenroth CB, Bikou O, et al
    Transmembrane Protein 100 Expression on Endothelial Cells Vascularizing Thrombi in Chronic Thromboembolic Pulmonary Hypertension Modulates TGFbeta1-ALK1 Signaling During Angiogenesis.
    Pulm Circ. 2026;16:e70253.
    PubMed    
    Abstract available
    
    

57. MOREIRA-COSTA L, Leite-Moreira A, Adao R, Laville D, et al
    A swine model of severe chronic thromboembolic pulmonary hypertension induced by repeated pulmonary artery long suture injection.
    Front Cardiovasc Med. 2026;12:1736958.
    PubMed    
    Abstract available
    
    

58. YUAN S, Hu X, Zhao Y, Dai H, et al
    Case Report: Immune checkpoint inhibitor-associated pulmonary hypertension.
    Front Cardiovasc Med. 2026;12:1705102.
    PubMed    
    Abstract available
    
    

59. DHAYYAT A, Stavem K, Jervan O, Hilde JM, et al
    Stress Echocardiography to Detect Exercise Pulmonary Hypertension in Patients With Chronic Thromboembolic Pulmonary Disease.
    Pulm Med. 2026;2026:4127338.
    PubMed    
    Abstract available
    
    

60. KANAGARAJ UK, Kuan MTY, Castaldo M, Skarsgard E, et al
    Liver herniation in congenital diaphragmatic hernia is associated with delayed resolution of pulmonary hypertension.
    Pediatr Neonatol. 2026 Jan 22:S1875-9572(26)00004.
    PubMed    
    Abstract available
    
    

61. LUI JK, Cozzolino M, Winburn M, Trojanowski MA, et al
    Risk stratifying systemic sclerosis-related pulmonary hypertension by left atrial strain.
    Rheumatology (Oxford). 2026 Jan 30:keag053. doi: 10.1093.
    PubMed    
    Abstract available
    
    

62. SHAUKAT M, Grunig E, Haas S, Haas J, et al
    Heritable pulmonary arterial hypertension: new genetic findings and environmental triggers.
    Sci Rep. 2026;16:4121.
    PubMed    
    Abstract available
    
    

63. WANG J, Wang Y, Shi R, Xu S, et al
    Allicin ameliorates right heart dysfunction in rats suffering from pulmonary arterial hypertension by regulating Ca(2+) communication between the sarcoplasmic reticulum and mitochondria.
    Biomed Pharmacother. 2026;195:119046.
    PubMed    
    Abstract available
    
    

64. LI Z, Chen K, Wu W
    Right atrial CCR2(+) macrophages mediate atrial fibrillation in rat with monocrotaline-induced pulmonary arterial hypertension.
    Int Immunopharmacol. 2026;172:115920.
    PubMed    
    Abstract available
    
    

65. CHEN Q, Jia N, Zhang X, Liu J, et al
    Calycosin ameliorates high-altitude pulmonary edema by regulating macrophage polarization through the PPAR-gamma/NF-kappaB pathway: a comprehensive analysis of network pharmacology, molecular docking, and experimental validation.
    J Ethnopharmacol. 2026;360:121200.
    PubMed    
    Abstract available
    
    

66. DE MARCO T, Paoli CJ, Germack HD, Croteau NS, et al
    Exploring the relationship between adherence and outcomes in pulmonary arterial hypertension: A retrospective cohort study in the United States.
    Respir Med. 2026;252:108649.
    PubMed    
    Abstract available
    
    

67. MA K, Zhu Y, Liu W, Zhu X, et al
    CMR-based estimation of mean pulmonary arterial pressure and pulmonary vascular resistance in connective tissue disease-associated pulmonary arterial hypertension.
    Clin Radiol. 2026;93:107199.
    PubMed    
    Abstract available
    
    

68. WATTANARAT B, Foocharoen C, Panitchote A
    Clinical predictors of mortality in critically ill systemic sclerosis patients: a 6-year retrospective cohort study.
    Rheumatology (Oxford). 2026;65:keag008.
    PubMed    
    Abstract available
    
    

69. WANG J, Jin J, Zhang M, Chen X, et al
    Mesenchymal stromal cells alleviate pulmonary arterial hypertension by suppressing pulmonary arterial adventitial fibroblast activation and extracellular matrix remodeling via the SOCS3/STAT3 pathway.
    Stem Cell Res Ther. 2026;17:67.
    PubMed    
    Abstract available
    
    

70. ISHIDA N, Oishi H, Niikawa H, Suzuki T, et al
    Bilateral lung transplantation with simultaneous aortic replacement using donor aorta in a patient with pulmonary arterial hypertension and patent ductus arteriosus.
    J Cardiothorac Surg. 2026;21:64.
    PubMed    
    Abstract available
    
    

71. QIAN W, Zhang Y, Dai J, Shan L, et al
    TAPSE/PASP combined with IVC can identify poor prognosis in PAH patients with low and intermediate risk.
    Clin Rheumatol. 2026;45:1215-1224.
    PubMed    
    Abstract available
    
    

72. CACHEUX M, Strauss B, Parajuli S, Halouani A, et al
    Extracellular-cAMP suppresses pulmonary arterial hypertension-induced ventricular arrhythmias.
    J Mol Cell Cardiol. 2026;211:109-118.
    PubMed    
    Abstract available
    
    

73. MELENDRES-GROVES LD, Channick RN, Chin KM, McLaughlin VV, et al
    Characteristics, Treatment Patterns and Outcomes of Patients with Pulmonary Arterial Hypertension by Race and Ethnicity Using Real-World Data from the Combined OPUS/OrPHeUS Studies.
    Adv Ther. 2026;43:231-254.
    PubMed    
    Abstract available
    
    

74. CLARKE M, Ataya A, Turkin AM, Parikh R, et al
    Transitioning Between Treprostinil Formulations: Evidence and Strategies.
    Adv Ther. 2026;43:20-48.
    PubMed    
    Abstract available
    
    

75. SEPLOWE M, Isath A, Michaud L, Frishman WH, et al
    Pulmonary Artery Hypertension: Fifty Years Following Pneumonectomy in Infancy.
    Cardiol Rev. 2026;34:175-177.
    PubMed    
    Abstract available
    
    

76. LIU JY, Chen J, Chen QY, Li HB, et al
    Liquid-liquid phase separation of EphB4 drives pulmonary hypertension via YAP activation.
    Cell Rep. 2026;45:116992.
    PubMed    
    Abstract available
    
    

77. AMBARDAR Y, Wazib S, Afghan S, Iqbal Alam M, et al
    Tribulus terrestris L. confers protection against hypoxia induced pulmonary hypertension via regulation of HIF/ NF-kappaB signalling pathway.
    J Ayurveda Integr Med. 2026;17:101296.
    PubMed    
    Abstract available
    
    

78. VON VISGER TT, Gill AS, Matura LA
    Mindfulness knowledge and practice in patients with cardiopulmonary conditions: A qualitative thematic analysis of adults living with pulmonary hypertension and chronic obstructive pulmonary disease(?).
    Heart Lung. 2026;78:102740.
    PubMed    
    Abstract available
    
    

79. NAVARRO-LLINARES L, Garcia-Leon B, de la Bastida-Casero L, Oliver E, et al
    The Vascular-Immune Cells Crosstalk and Microenvironment in Pulmonary Hypertension.
    Compr Physiol. 2026;16:e70110.
    PubMed    
    Abstract available
    
    

80. ZHOU J
    Prevalence and risk factors of pulmonary hypertension in maintenance hemodialysis patients based on echocardiography.
    Medicine (Baltimore). 2026;105:e43845.
    PubMed    
    Abstract available
    
    

81. NAIDOO A
    Survival in sight: Rethinking PDE5 inhibitors in ILD-associated pulmonary hypertension.
    Afr J Thorac Crit Care Med. 2025;31:e2720.
    PubMed    
    
    
    

82. FU X, Lei C, Xu A, Yuan L, et al
    Combined Effects of Pulmonary Hypertension and Heart Valve Calcification on Cardiovascular Outcomes in Maintenance Hemodialysis Patients: A Risk Stratification Study Using Echocardiography.
    Kidney Dis (Basel). 2025;12:129-139.
    PubMed    
    Abstract available
    
    

83. LUCA AC, Rosu ST, Diaconescu C, Mindru DE, et al
    The First 1000 Days: Maternal Nutrient Intake-A Window of Opportunity for Pulmonary Hypertension-A Narrative Review.
    Nutrients. 2026;18:424.
    PubMed    
    Abstract available
    
    

84. HIRONO K, Uchida K, Ishii T, Ishida H, et al
    Systematic Review of the Application of Pulmonary Hypertension Treatments in Ventricular Septal Defect, Pulmonary Atresia, and Major Aortopulmonary Collateral Arteries.
    J Clin Med. 2026;15:1087.
    PubMed    
    Abstract available
    
    

85. LIU YS, Lin YC, Tsai SC, Wang HY, et al
    Diagnostic Performance of Quantitative Lung Perfusion SPECT/CT for Chronic Thromboembolic Pulmonary Hypertension: A Pilot Study.
    Diagnostics (Basel). 2026;16:413.
    PubMed    
    Abstract available
    
    

86. ZHU Y, Cui L, Zhou T, Xu H, et al
    The quality and reliability of short videos about pulmonary hypertension on Bilibili and TikTok: a cross-sectional study.
    BMC Cardiovasc Disord. 2026 Feb 12. doi: 10.1186/s12872-026-05597.
    PubMed    
    
    
    

87. ZHANG Y, Dai Q, Gong L, Zheng R, et al
    Integrative Machine Learning and Experimental Validation Identify FIS1 as a Candidate Biomarker Linked to Mitochondrial Dynamics in Pulmonary Hypertension.
    Cells. 2026;15:301.
    PubMed    
    Abstract available
    
    

88. REGUERA JV, Ortega PP, San Martin Bragado M, Belloch MC, et al
    Extracorporeal Cardiopulmonary Resuscitation due to Left Atrial Myxoma With Severe Pulmonary Hypertension: A Challenging Combination.
    JACC Case Rep. 2026 Feb 12:106957. doi: 10.1016/j.jaccas.2026.106957.
    PubMed    
    Abstract available
    
    

89. TAGER D, Collier P, Akintoye EO, Wang Y, et al
    Echocardiographic Assessment After Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension: Which Parameters Reflect Improved Right Ventricular Function?
    Pulm Circ. 2026;16:e70261.
    PubMed    
    Abstract available
    
    

90. CAI D, Zhou R, Fujise K, Chen SY, et al
    Murine Aortopulmonary Shunt Model of Flow-Driven Pulmonary Hypertension.
    Arterioscler Thromb Vasc Biol. 2026 Feb 12:10.1161/ATVBAHA.125.323657.
    PubMed    
    Abstract available
    
    

91. LI L, Huang X, Cheng M, He C, et al
    Pulmonary hypertension: etiology and anti-inflammatory treatment pathways of natural products.
    Front Pharmacol. 2026;16:1743782.
    PubMed    
    Abstract available
    
    

92. WEI H, Guo S, Ding W, Yang Y, et al
    Altered gut microbial dynamics and the antivascular remodeling effect of carnosine in hypobaric hypoxic pulmonary hypertension rats.
    Acta Biochim Biophys Sin (Shanghai). 2026 Feb 10. doi: 10.3724/abbs.2025237.
    PubMed    
    Abstract available
    
    

93. THAKUR A, Thakur A, Bhatia K
    Letter to the Editor: Pulmonary Hypertension as a Determinant of In-Hospital Mortality in COPD: Insights and Methodological Considerations.
    COPD. 2026;23:2621733.
    PubMed    
    
    
    

94. DING S, Chen J, Li Z, Yu Y, et al
    Cellular Signalling Networks in High Altitude Pulmonary Hypertension: From Canonical Pathways to Emerging Targets.
    Cell Prolif. 2026 Feb 10:e70179. doi: 10.1111/cpr.70179.
    PubMed    
    Abstract available
    
    

95. PAGNONI G, Vicenzi A, Coppi F
    Right Atrial Function and Tricuspid Regurgitation in Chronic Thromboembolic Pulmonary Hypertension.
    Echocardiography. 2026;43:e70406.
    PubMed    
    
    
    

96. BARSAIN M, Parveen R, Devi K, Tomar MS, et al
    Improving mitochondrial health by pyrroloquinoline quinone (PQQ) prevents ultrafine carbon particle (UFCP) induced emphysema and associated pulmonary hypertension.
    Free Radic Biol Med. 2026;247:267-285.
    PubMed    
    Abstract available
    
    

97. LI XM, Yang L, Yang ZG
    Taussig-Bing heart with pulmonary hypertension in a rare adult survivor: multimodality imaging insights.
    Eur Heart J. 2026 Feb 9:ehag026. doi: 10.1093.
    PubMed    
    
    
    

98. WANG M, Song J, Yu Y, Chen R, et al
    An applied study on the assessment of concomitant pulmonary hypertension in patients with chronic obstructive pulmonary disease based on whole-lung CT imaging histologic features.
    J Thorac Dis. 2026;18:18.
    PubMed    
    Abstract available
    
    

99. ZHANG X, Yang J, Yang Z, Liu T, et al
    Current Evidence on the Potential Role of Endothelial SHP-1 in Pulmonary Vascular Remodeling Associated With Pulmonary Hypertension.
    Rev Cardiovasc Med. 2026;27:39059.
    PubMed    
    Abstract available
    
    

100. DENG X, Yuan T, Qian J, Wang Q, et al
     Rare TRAF5 coding variants in systemic lupus erythematosus patients aggravate pulmonary hypertension via endothelial dysfunction.
     Innovation (Camb). 2025;7:101111.
     PubMed    
     Abstract available
     
     

101. ALESSANDRA G, Beatrice M, Sara C, Roberta M, et al
     Preselected and preferred immersive virtual reality versus narrative alone to induce post-stress relaxation in patients with pulmonary arterial hypertension: A pilot study on perceived stress and heart rate.
     Br J Health Psychol. 2026;31:e70059.
     PubMed    
     Abstract available
     
     

102. CINAR C, Yildizeli SO, Atas H, Balcan B, et al
     Obstructive sleep apnea and echocardiographic indicators of elevated pulmonary hypertension probability after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension.
     Sleep Med. 2026;141:108827.
     PubMed    
     Abstract available
     
     

103. GENTLE SJ, Hebert A
     Beyond the Echocardiogram: Cardiac Catheterization in Infants With Bronchopulmonary Dysplasia Associated Pulmonary Hypertension.
     J Pediatr. 2026 Feb 5:115026. doi: 10.1016/j.jpeds.2026.115026.
     PubMed    
     
     
     

104. LEUILLIER M, Chelgham M, Messaoudi H, Tu L, et al
     Inactivation of the Phosphatase Activity of Soluble Epoxide Hydrolase Modulates SIRT3 and Attenuates Experimental Pulmonary Hypertension.
     Compr Physiol. 2026;16:e70108.
     PubMed    
     Abstract available
     
     

105. CHANG WT, Shih JY, Lin CH, Hsu CH, et al
     Exosomal miR-21 mitigates pulmonary hypertension-induced right-heart remodeling by preserves mitochondrial homeostasis.
     J Transl Med. 2026 Feb 6. doi: 10.1186/s12967-026-07795.
     PubMed    
     
     
     

106. ZHANG C, Huang T, Guo X, Fan Y, et al
     Hemoglobin adduction and impaired oxygen transport define the etiology of pyrrolizidine alkaloid-induced pulmonary arterial hypertension.
     Phytomedicine. 2026;152:157847.
     PubMed    
     Abstract available
     
     

107. YIN Q, Xiong Z, Wang X, Wei TW, et al
     Paeonol alleviates pulmonary arterial hypertension by activation of BRCC3.
     Phytomedicine. 2026;152:157888.
     PubMed    
     Abstract available
     
     

108. CHE H, Yi J, Li J, Hu Y, et al
     Unveiling the protective mechanisms of Pipa Qingfei Decoction in pulmonary arterial hypertension: Insights from network pharmacology, metabolomics and Mendelian randomization.
     J Ethnopharmacol. 2026;361:121287.
     PubMed    
     Abstract available
     
     

109. DE ARAUJO ALVES CC, Santos RS, Rocha NN, Felix NS, et al
     Targeting pulmonary arterial hypertension with aerobic training: anti-inflammatory and cardioprotective effects enhance survival in experimental models.
     J Appl Physiol (1985). 2026;140:577-588.
     PubMed    
     Abstract available
     
     

110. ZHOU J, Yang Y, Zou H, Jiang X, et al
     A carrier-free nanomedicine targeting vascular remodeling and oxidative stress for enhanced pulmonary arterial hypertension therapy.
     J Colloid Interface Sci. 2026;708:139821.
     PubMed    
     Abstract available
     
     

111. CETIN GUVENC R, Guvenc TS, Karakaya ES, Acik H, et al
     Abnormal Right Ventricular to Pulmonary Artery Coupling in Patients with End-Stage Kidney Disease and Normalization After Renal Transplantation: An Observational Study.
     Nephron. 2025 Oct 30:1-18. doi: 10.1159/000549077.
     PubMed    
     Abstract available
     
     

112. AUSTIN ED, Mullen MP, Avitabile CM, Krishnan US, et al
     Pulmonary Hemodynamics and Long-Term Outcomes in Children with Pulmonary Hypertension-Associated Bronchopulmonary Dysplasia.
     J Pediatr. 2026;289:114869.
     PubMed    
     Abstract available
     
     

113. GENSKE F, Rawish E, Macherey-Meyer S, Buchel C, et al
     Comparison of different venous access ways for right heart catheterization-a meta-analysis.
     Hellenic J Cardiol. 2026;87:121-132.
     PubMed    
     Abstract available
     
     

114. GUDER G, Reiter T, Fette G, Hundertmark M, et al
     Diagnosing post-capillary hypertension in patients with left heart disease: impact of new guidelines.
     Clin Res Cardiol. 2026;115:395-404.
     PubMed    
     Abstract available
     
     

115. PASQUINUCCI M, Bonsembiante L, Mezzalira S, Locallo M, et al
     A Rare Case of Reversible Pulmonary Hypertension Phenotype in a Child with Scurvy: Aetiologies Insights.
     Reports (MDPI). 2026;9:44.
     PubMed    
     Abstract available
     
     

116. ALRASHEDI S, Alharbi L, Alotaibi M, Alzahrani I, et al
     Evaluating the Impact of Inspiratory Muscle Training on Respiratory Function and Exercise Capacity in Pulmonary Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
     Adv Respir Med. 2026;94:13.
     PubMed    
     Abstract available
     
     

117. SCELSI L, Badagliacca R, D'Alto M, Acquaro M, et al
     Value of right heart haemodynamics for risk stratification of patients with pulmonary arterial hypertension at follow-up.
     ESC Heart Fail. 2026;13:xvaf012.
     PubMed    
     Abstract available
     
     

118. MELIN M, Lofman IH, Matan D, Nygren M, et al
     Agreement of thermodilution and direct Fick methods for cardiac output across varying haemodynamic conditions.
     ESC Heart Fail. 2026;13:xvaf001.
     PubMed    
     Abstract available
     
     

119. MILES KG, Dorobantu DM, Douwes JM, Frank BS, et al
     Current State of RV Multimodality Imaging in Pediatric Pulmonary Hypertension: Current Evidence, Knowledge Gaps, and Future Research Directions.
     Circ Cardiovasc Imaging. 2026 Feb 19:e019264.
     PubMed    
     Abstract available
     
     

120. HOWARD LS, Kiely DG, Lawrie A, Maron BA, et al
     Performance of Guideline-Recommended Approaches to Echocardiographic Investigation for Pulmonary Hypertension: Analysis of the CIPHER Study.
     Pulm Circ. 2026;16:e70258.
     PubMed    
     Abstract available
     
     

121. VILLA A, Sanges S, Sobanski V, Lamblin N, et al
     Management of pulmonary arterial hypertension in systemic sclerosis: from classical treatments to new horizons.
     Eur Respir Rev. 2026;35:250137.
     PubMed    
     Abstract available
     
     

122. LI H, Li M, Qiu C, Yang Y, et al
     Bulk and single-cell transcriptomics for identification of potential diagnostic biomarkers associated with pulmonary arterial hypertension and integrated stress response and experimental validation.
     Clin Exp Hypertens. 2026;48:2629926.
     PubMed    
     Abstract available
     
     

123. MOHAMED-ALI N, Acquaah V, Al-Jaber M, Bhatt R, et al
     Systemic sclerosis-associated pulmonary arterial hypertension and pulmonary fibrosis: exploring biomarker discriminators with advanced omics in a Caucasian cohort.
     Front Immunol. 2026;17:1755076.
     PubMed    
     Abstract available
     
     

124. RIOU M, Beurnier A, Montani D
     Pulmonary hypertension associated with COPD: exploring the complex spectrum of an unmet clinical challenge.
     ERJ Open Res. 2026;12:01153-2025.
     PubMed    
     Abstract available
     
     

125. TSANG KD, Caudri D, Zaat C, Tramper-Stranders GA, et al
     Peri and Neonatal Risk Factors and Structural Lung Abnormalities Predict Hypoxic Challenge Test Failure in Infants With Severe Bronchopulmonary Dysplasia.
     Pediatr Pulmonol. 2026;61:e71517.
     PubMed    
     Abstract available
     
     

126. ALOWAMI M, Ch'ng BX, Babasola RO, Tan CH, et al
     Efficacy and Safety of Selexipag in Pulmonary Hypertension: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
     Cardiol Rev. 2026 Feb 18. doi: 10.1097/CRD.0000000000001185.
     PubMed    
     Abstract available
     
     

127. YAMAMOTO S, Sakamaki F
     Current perspectives on imaging modalities in the diagnosis and management of pulmonary hypertension.
     Respir Investig. 2026;64:101389.
     PubMed    
     Abstract available
     
     

128. CHENG K, Zheng T, Guo L, Guo M, et al
     GLI1 Promotes Hypoxia Induced Pyroptosis of PASMCs and Aggravates Pulmonary Arterial Hypertension in Rats by Upregulating HDAC1 Expression.
     Cardiovasc Toxicol. 2026;26:28.
     PubMed    
     Abstract available
     
     

129. WANG B, Zhang Z, Chen K, Qin Y, et al
     Fatal pulmonary artery dissection in the setting of aneurysm and pulmonary hypertension: a case report and literature review.
     J Cardiothorac Surg. 2026 Feb 16. doi: 10.1186/s13019-026-03880.
     PubMed    
     
     
     

130. MANCA P, Puglisi S, Pascalis L, Nuzzi V, et al
     Prognostic Role of Invasively Determined Pulmonary Hypertension in Ambulatory Patients with Advanced Heart Failure: A Prospective Cohort Study.
     Curr Probl Cardiol. 2026 Feb 14:103301. doi: 10.1016/j.cpcardiol.2026.103301.
     PubMed    
     Abstract available
     
     

131. BHADRA OD, Weimann J, Waldschmidt L, Demal TJ, et al
     Long-term outcome of patients with severe pulmonary hypertension undergoing transcatheter aortic valve implantation.
     Front Cardiovasc Med. 2026;12:1678025.
     PubMed    
     Abstract available
     
     

132. PHU QUY H, Doan Duc D, Nguyen Duc T
     A diagnostic challenge: unveiling chronic thromboembolic pulmonary hypertension in the absence of visible thrombi: a case report.
     Eur Heart J Case Rep. 2026;10:ytag034.
     PubMed    
     Abstract available
     
     

133. NICOL C, Kristrom K, Bettembourg V
     Case Report: Anaesthetic management in a canine patient with severe atrioventricular septal defect and pulmonary hypertension undergoing non-cardiac surgery.
     Front Vet Sci. 2026;13:1736215.
     PubMed    
     Abstract available
     
     

134. GUPFERT M, Weber L, Haager PK, Baier P, et al
     Impact of Right Heart Catheterization and the 2022 ESC/ERS Definition of Pulmonary Hypertension in Patients With Mitral Regurgitation Undergoing Valve Repair/Replacement.
     Pulm Circ. 2026;16:e70265.
     PubMed    
     Abstract available
     
     

135. KUME H, Nosaka N, Yasumura R
     Venoarterial Extracorporeal Membrane Oxygenation Rescue for Catastrophic Grade 3 Bone Cement Implantation Syndrome in a Patient With Aortic Valve Stenosis and Moderate Pulmonary Hypertension: A Case Report.
     Cureus. 2026;18:e101514.
     PubMed    
     Abstract available
     
     

136. QUE W, Li S, Li J, Li Y, et al
     The effect of atorvastatin combined with azithromycin on lung function and right heart function in COPD patients with concomitant pulmonary hypertension.
     Front Med (Lausanne). 2026;12:1667773.
     PubMed    
     Abstract available
     
     

137. SIUBA MT, Lane J, Mendpara V, Toth D, et al
     Cardiac Output During Exercise: Thermodilution Versus Direct Fick.
     J Am Heart Assoc. 2026;15:e047657.
     PubMed    
     Abstract available
     
     

138. QI Y, Dong Q, Luo P, Meng J, et al
     USP15 promotes proliferation, migration, and apoptosis resistance of pulmonary arterial smooth muscle cells by targeting MDM2.
     Arch Biochem Biophys. 2026;778:110733.
     PubMed    
     Abstract available
     
     

139. HABIB NG, Adhia A, Lopez D, Sandros M, et al
     Selection of Endothelin Receptor Antagonists in the Treatment of Pulmonary Arterial Hypertension: A Comprehensive Narrative Review.
     Adv Ther. 2026;43:468-519.
     PubMed    
     Abstract available
     
     

140. NOH CY, Danzer E, Bhombal S, Chock VY, et al
     Early postnatal echocardiographic characteristics impact survival and extracorporeal life support in congenital diaphragmatic hernia.
     Pediatr Res. 2025 Oct 1. doi: 10.1038/s41390-025-04443.
     PubMed    
     Abstract available
     
     

141. JENKINSON A, Harris C, Bafadhel M, Razavi R, et al
     Longitudinal changes in cardiopulmonary outcomes of adults born extremely prematurely: United Kingdom Oscillation Study.
     Pediatr Res. 2025 Jun 16. doi: 10.1038/s41390-025-04190.
     PubMed    
     Abstract available
     
     

142. CHEN Q, Lin L, Xiong S, Ge D, et al
     Risk factors for severe pertussis in children and the application of exchange transfusion.
     Pediatr Res. 2026;99:248-253.
     PubMed    
     Abstract available
     
     

143. OAKLAND HT, Bellumkonda L, Sugeng L, Joseph P, et al
     3D echo derived right ventricular principal surface strain in pulmonary arterial hypertension.
     Am J Physiol Heart Circ Physiol. 2026;330:H729-H736.
     PubMed    
     Abstract available
     
     

144. BHADRA A, Bonnie F, Hewes J, Patel M, et al
     cAMP-enriched extracellular vesicles improve outcomes in pulmonary hypertension.
     Am J Physiol Lung Cell Mol Physiol. 2026;330:L169-L177.
     PubMed    
     Abstract available
     
     

145. CHANDEL A, Turkington S, King CS, Singhal A, et al
     Pulmonary hypertension prevalence and significance in lung transplant recipients with cystic fibrosis and non-cystic fibrosis bronchiectasis.
     Chest. 2026 Jan 27:S0012-3692(26)00127-3. doi: 10.1016/j.chest.2025.
     PubMed    
     Abstract available
     
     

146. LANG IM
     Chronic Thromboembolic Pulmonary Hypertension and Elevated Pulmonary Arterial Wedge Pressure: No Fear of BPA!
     Chest. 2026;169:322-323.
     PubMed    
     
     
     

147. TORO V, Mougin M, Brossat C, Jambon-Barbara C, et al
     Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension.
     Circulation. 2026 Jan 28. doi: 10.1161/CIRCULATIONAHA.125.079067.
     PubMed    
     Abstract available
     
     

148. TADA A, Fayyaz AU, Reddy YNV, Redfield MM, et al
     Rapidly Progressive Pulmonary Hypertension: Importance of Vascular Disease Distribution.
     Circulation. 2026;153:285-289.
     PubMed    
     
     
     

149. REDDY YNV, Frantz RP, Miranda WR, Asokan AK, et al
     Elevated Pulmonary Artery Wedge Pressure in Group 1 Pulmonary Hypertension.
     Circulation. 2026 Feb 13. doi: 10.1161/CIRCULATIONAHA.125.077606.
     PubMed    
     Abstract available
     
     

150. REDDY YNV, Frantz RP, Miranda WR, Varma R, et al
     Pathophysiology and prevalence of high output heart failure in group 1 pulmonary hypertension.
     Eur Respir J. 2026 Feb 19:2501871. doi: 10.1183/13993003.01871-2025.
     PubMed    
     Abstract available
     
     

151. JUTANT EM, Grynblat J, Pyrrait M, Lechartier B, et al
     Pulmonary hypertension associated with hereditary hemorrhagic telangiectasia: from genetics to clinical management.
     Eur Respir J. 2026 Feb 19:2502322. doi: 10.1183/13993003.02322-2025.
     PubMed    
     Abstract available
     
     

152. GOPAGONDANAHALLI KR, Tan JM, Khoo May Lyn J, Sundararaghavan S, et al
     Variable clinical and hemodynamic effect of sildenafil in extreme premature infants with bronchopulmonary dysplasia-associated pulmonary hypertension.
     J Perinatol. 2026 Feb 5. doi: 10.1038/s41372-026-02578.
     PubMed    
     Abstract available
     
     

153. FOOTE HP, Sun M, Goldstein BA, Hill KD, et al
     Predicting pulmonary hypertension in infants with bronchopulmonary dysplasia.
     J Perinatol. 2026 Feb 16. doi: 10.1038/s41372-026-02576.
     PubMed    
     Abstract available
     
     

154. RAMACHANDRA R, Arunamata A, Moy A, Tracy MC, et al
     Results of a pulmonary hypertension screening program for premature infants with bronchopulmonary dysplasia.
     J Perinatol. 2026 Feb 16. doi: 10.1038/s41372-026-02580.
     PubMed    
     Abstract available
     
     

155. MORRIS H, Reilly M, Zhang H, Dong X, et al
     Characteristics associated with death or tracheostomy in infants with bronchopulmonary dysplasia following predominant non-invasive respiratory support.
     J Perinatol. 2025 Feb 22. doi: 10.1038/s41372-025-02234.
     PubMed    
     Abstract available
     
     

156. SHENTU J, Dai W, Chen C, Huang J, et al
     A Novel Rat Model for Group 2 Pulmonary Hypertension by Total Pulmonary Vein Banding: Multi-Omics Insights into Pathophysiological Mechanisms.
     J Thorac Cardiovasc Surg. 2026 Jan 29:S0022-5223(26)00085.
     PubMed    
     Abstract available
     
     

157. CHEN KL, Duemmel S, Christof M, Wang G, et al
     Mixed effects of complement in a chronic murine model of inflammatory erosive arthritis and pulmonary vascular disease.
     PLoS One. 2026;21:e0340677.
     PubMed    
     Abstract available
     
     

158. OPATRIL L, Mojica-Pisciotti ML, Panovsky R, Machal J, et al
     Comparison of pulmonary circulation parameters acquired by cardiovascular magnetic resonance with right heart catheterization and transthoracic echocardiography in patients with recent-onset dilated cardiomyopathy.
     PLoS One. 2026;21:e0341438.
     PubMed    
     Abstract available
     
     

159. LEBENDER LF, Seidinger A, Matthey M, Dyck B, et al
     Beta arrestin 1 is a key regulator of pulmonary vascular tone.
     Proc Natl Acad Sci U S A. 2026;123:e2512602123.
     PubMed    
     Abstract available